Metabolic Plasticity of Metastatic Breast Cancer Cells: Adaptation to Changes in the Microenvironment

Neoplasia (United States)

Volumn 17, Issue 8, 2015, Pages 671-684

  Simões, Rui V ^a,d   Serganova, Inna S ^a   Kruchevsky, Natalia ^a   Leftin, Avigdor ^a   Shestov, Alexander A ^b,e   Thaler, Howard T ^a   Sukenick, George ^a   Locasale, Jason W ^b,f   Blasberg, Ronald G ^a   Koutcher, Jason A ^a,c   Ackerstaff, Ellen ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Memorial Sloan Kettering Cancer Center ^*  (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF BARCELONA   (Spain)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f DUKE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; GLUTAMINE; LACTIC ACID; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE SUBUNIT A; SUCCINIC ACID; UNCLASSIFIED DRUG; PHOSPHOLIPID;

ADAPTATION; ANIMAL CELL; ARTICLE; BREAST CANCER CELL LINE; BREAST METASTASIS; CARBON NUCLEAR MAGNETIC RESONANCE; CELL METABOLISM; CELL PLASTICITY; CELL PROLIFERATION; CITRIC ACID CYCLE; CONTROLLED STUDY; ENVIRONMENTAL STRESS; GLYCOLYSIS; METABOLIC STRESS; METASTASIS POTENTIAL; MICROMETASTASIS; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; DRUG EFFECTS; ENERGY METABOLISM; EXPERIMENTAL MAMMARY NEOPLASM; METABOLISM; METASTASIS; PATHOLOGY; PH; PROCEDURES; TUMOR CELL LINE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CARBON-13 MAGNETIC RESONANCE SPECTROSCOPY; CELL LINE, TUMOR; CELL SURVIVAL; CITRIC ACID CYCLE; ENERGY METABOLISM; GLUCOSE; GLUTAMINE; GLYCOLYSIS; HYDROGEN-ION CONCENTRATION; MAMMARY NEOPLASMS, ANIMAL; MICE, INBRED BALB C; NEOPLASM METASTASIS; OXIDATIVE PHOSPHORYLATION; PHOSPHOLIPIDS; TUMOR MICROENVIRONMENT;

EID: 84963957265     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1016/j.neo.2015.08.005     Document Type: Article

References (55)

1. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012, 62:220-241.
2. Chiang AC, Massague J Molecular basis of metastasis. N Engl J Med 2008, 359:2814-2823.
3. Fidler IJ, Kripke ML Metastasis results from preexisting variant cells within a malignant tumor. Science 1977, 197:893-895.
4. Bianchini G, Qi Y, Alvarez RH, Iwamoto T, Coutant C, Ibrahim NK, Valero V, Cristofanilli M, Green MC, Radvanyi L, et al. Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers. J Clin Oncol 2010, 28:4316-4323.
5. Rattigan YI, Patel BB, Ackerstaff E, Sukenick G, Koutcher JA, Glod JW, Banerjee D Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment. Exp Cell Res 2012, 318:326-335.
6. Gatenby RA, Smallbone K, Maini PK, Rose F, Averill J, Nagle RB, Worrall L, Gillies RJ Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br J Cancer 2007, 97:646-653.
7. Vaupel P, Kallinowski F, Okunieff P Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989, 49:6449-6465.
8. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008, 7:11-20.
9. Vander Heiden MG, Cantley LC, Thompson CB Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
10. Cairns RA, Harris IS, Mak TW Regulation of cancer cell metabolism. Nat Rev Cancer 2011, 11:85-95.
11. Warburg O, Wind F, Negelein E The metabolism of tumors in the body. J Gen Physiol 1927, 8:519-530.
12. Lyon RC, Cohen JS, Faustino PJ, Megnin F, Myers CE Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy. Cancer Res 1988, 48:870-877.
13. Bohndiek SE, Brindle KM Imaging and 'omic' methods for the molecular diagnosis of cancer. Expert Rev Mol Diagn 2010, 10:417-434.
14. Gatenby RA, Gillies RJ Why do cancers have high aerobic glycolysis?. Nat Rev Cancer 2004, 4:891-899.
15. Webb BA, Chimenti M, Jacobson MP, Barber DL Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer 2011, 11:671-677.
16. Aslakson CJ, Miller FR Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 1992, 52:1399-1405.
17. Serganova I, Rizwan A, Ni X, Thakur SB, Vider J, Russell J, Blasberg R, Koutcher JA Metabolic imaging: a link between lactate dehydrogenase A, lactate, and tumor phenotype. Clin Cancer Res 2011, 17:6250-6261.
18. Jose C, Bellance N, Rossignol R Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma?. Biochim Biophys Acta 2011, 1807:552-561.
19. Chen EI, Hewel J, Krueger JS, Tiraby C, Weber MR, Kralli A, Becker K, Yates JR, Felding-Habermann B Adaptation of energy metabolism in breast cancer brain metastases. Cancer Res 2007, 67:1472-1486.
20. Bonuccelli G, Tsirigos A, Whitaker-Menezes D, Pavlides S, Pestell RG, Chiavarina B, Frank PG, Flomenberg N, Howell A, Martinez-Outschoorn UE, et al. Ketones and lactate "fuel" tumor growth and metastasis: evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 2010, 9:3506-3514.
21. Lu X, Bennet B, Mu E, Rabinowitz J, Kang Y Metabolomic changes accompanying transformation and acquisition of metastatic potential in a syngeneic mouse mammary tumor model. J Biol Chem 2010, 285:9317-9321.
22. Invernizzi F, D'Amato I, Jensen PB, Ravaglia S, Zeviani M, Tiranti V Microscale oxygraphy reveals OXPHOS impairment in MRC mutant cells. Mitochondrion 2012, 12:328-335.
23. Rizwan A, Serganova I, Khanin R, Karabeber H, Ni X, Thakur SB, Zakian KL, Blasberg RG, Koutcher JA Relationships between LDH-A, lactate and metastases in 4T1 breast tumors. Clin Cancer Res 2013, 19:5158-5169.
24. 13C NMR spectroscopic changes during chemotherapy-induced apoptosis in human glioma cells. Magn Reson Med 2005, 54:67-78.
25. Wehrle JP, Ng CE, McGovern KA, Aiken NR, Shungu DC, Chance EM, Glickson JD Metabolism of alternative substrates and the bioenergetic status of EMT6 tumor cell spheroids. NMR Biomed 2000, 13:349-360.
26. Smirnova T, Zhou ZN, Flinn RJ, Wyckoff J, Boimel PJ, Pozzuto M, Coniglio SJ, Backer JM, Bresnick AR, Condeelis JS, et al. Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis. Oncogene 2012, 31:706-715.
27. DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, Thompson CB Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A 2007, 104:19345-19350.
28. Wise DR, Thompson CB Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci 2010, 35:427-433.
29. Owen OE, Kalhan SC, Hanson RW The key role of anaplerosis and cataplerosis for citric acid cycle function. J Biol Chem 2002, 277:30409-30412.
30. 13C NMR spectroscopy and metabolic modeling in the brain: a practical perspective. Magn Reson Imaging 2006, 24:527-539.
31. Metallo CM, Gameiro PA, Bell EL, Mattaini KR, Yang J, Hiller K, Jewell CM, Johnson ZR, Irvine DJ, Guarente L, et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 2012, 481:380-384.
32. Mullen AR, Wheaton WW, Jin ES, Chen PH, Sullivan LB, Cheng T, Yang Y, Linehan WM, Chandel NS, DeBerardinis RJ Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 2012, 481:385-388.
33. Le A, Lane AN, Hamaker M, Bose S, Gouw A, Barbi J, Tsukamoto T, Rojas CJ, Slusher BS, Zhang H, et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab 2012, 15:110-121.
34. Scaglia F, Carter S, O'Brien WE, Lee B Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients. Mol Genet Metab 2004, 81(Suppl. 1):S79-S85.
35. Braulio VB, Ten Have GA, Vissers YL, Deutz NE Time course of nitric oxide production after endotoxin challenge in mice. Am J Physiol Endocrinol Metab 2004, 287:E912-E918.
36. Semenza GL Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol 2009, 19:12-16.
37. Golinska M, Troy H, Chung YL, McSheehy PM, Mayr M, Yin X, Ly L, Williams KJ, Airley RE, Harris AL, et al. Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomas. BMC Cancer 2011, 11:198.
38. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB, Gottlieb E Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 2005, 7:77-85.
39. Semenza GL Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003, 3:721-732.
40. Lou Y, McDonald PC, Oloumi A, Chia S, Ostlund C, Ahmadi A, Kyle A, Auf dem Keller U, Leung S, Huntsman D, et al. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 2011, 71:3364-3376.
41. Huang KT, Dobrovic A, Fox SB No evidence for promoter region methylation of the succinate dehydrogenase and fumarate hydratase tumour suppressor genes in breast cancer. BMC Res Notes 2009, 2:194.
42. Kim S, Kim do H, Jung WH, Koo JS Succinate dehydrogenase expression in breast cancer. Springerplus 2013, 2:299.
43. Dong C, Yuan T, Wu Y, Wang Y, Fan TW, Miriyala S, Lin Y, Yao J, Shi J, Kang T, et al. Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell 2013, 23:316-331.
44. Mullen AR, Hu Z, Shi X, Jiang L, Boroughs LK, Kovacs Z, Boriack R, Rakheja D, Sullivan LB, Linehan WM, et al. Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects. Cell Rep 2014, 7:1679-1690.
45. Whitaker-Menezes D, Martinez-Outschoorn UE, Flomenberg N, Birbe RC, Witkiewicz AK, Howell A, Pavlides S, Tsirigos A, Ertel A, Pestell RG, et al. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue. Cell Cycle 2011, 10:4047-4064.
46. Guppy M, Leedman P, Zu X, Russell V Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. Biochem J 2002, 364:309-315.
47. Meadows AL, Kong B, Berdichevsky M, Roy S, Rosiva R, Blanch HW, Clark DS Metabolic and morphological differences between rapidly proliferating cancerous and normal breast epithelial cells. Biotechnol Prog 2008, 24:334-341.
48. Fogal V, Richardson AD, Karmali PP, Scheffler IE, Smith JW, Ruoslahti E Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation. Mol Cell Biol 2010, 30:1303-1318.
49. Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, Nissim I, Daikhin E, Yudkoff M, McMahon SB, et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci U S A 2008, 105:18782-18787.
50. Tao K, Fang M, Alroy J, Sahagian GG Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer 2008, 8:228.
51. Singh B, Tai K, Madan S, Raythatha MR, Cady AM, Braunlin M, Irving LR, Bajaj A, Lucci A Selection of metastatic breast cancer cells based on adaptability of their metabolic state. PLoS One 2012, 7:e36510.
52. Yang L, Moss T, Mangala LS, Marini J, Zhao H, Wahlig S, Armaiz-Pena G, Jiang D, Achreja A, Win J, et al. Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer. Mol Syst Biol 2014, 10:728.
53. Richardson AD, Yang C, Osterman A, Smith JW Central carbon metabolism in the progression of mammary carcinoma. Breast Cancer Res Treat 2008, 110:297-307.
54. Zhang J, Fan J, Venneti S, Cross JR, Takagi T, Bhinder B, Djaballah H, Kanai M, Cheng EH, Judkins AR, et al. Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion. Mol Cell 2014, 56:205-218.
55. Fokas E, Engenhart-Cabillic R, Daniilidis K, Rose F, An HX Metastasis: the seed and soil theory gains identity. Cancer Metastasis Rev 2007, 26:705-715.